Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected

BACKGROUND AIMS: A phase I trial examined the ability of immunotherapy to mobilize progenitor and activated T cells. METHODS: Interleukin (IL)-2 was administered subcutaneously for 11 days, with granulocyte (G)-colony-stimulating factor (CSF) (5 mcg/kg/day) and granulocyte–macrophage (GM)-CSF (7.5 m...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: MEEHAN, KENNETH R., TALEBIAN, LALEH, WU, JILLIAN, HILL, JOHN M., SZCZEPIORKOWSKI, ZBIGNIEW M., SENTMAN, CHARLES L., ERNSTOFF, MARC S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3280590/
https://ncbi.nlm.nih.gov/pubmed/20873991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2010.515580
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky